Chicken Infectious Anemia

Chicken infectious anemia (CIA) is a highly contagious, immunosuppressive viral disease of young chickens caused by Chicken anemia virus (CAV), a small, non-enveloped, single-stranded DNA virus belonging to the genus Gyrovirus in the family Anelloviridae. The disease is characterized by severe aplastic anemia, generalized lymphoid atrophy, and subsequent immunosuppression, leading to increased susceptibility to secondary bacterial, viral, and fungal infections. CIA primarily affects broiler chicks between 2 and 4 weeks of age, but can also cause disease in commercial layers and broiler breeders, particularly when maternal immunity is inadequate. The virus has a worldwide distribution and poses significant economic losses to the poultry industry due to increased mortality, poor growth performance, and increased condemnation rates at processing. In addition to clinical disease, subclinical infections are common and can exacerbate the severity of other poultry diseases, such as infectious bursal disease (IBD) and Marek's disease (MD). The disease is also known as chicken infectious anemia virus (CIAV) infection, avian anemia, and blue wing disease (in some European countries).

The etiological agent is Chicken anemia virus (CAV), a small (approximately 25 nm in diameter), non-enveloped, icosahedral virus with a single-stranded, circular DNA genome of about 2.3 kilobases. CAV is the only member of the genus Gyrovirus within the family Anelloviridae. The virus is highly resistant to environmental conditions, including heat (stable at 70°C for 1 hour), acid (pH 3), and common disinfectants, which contributes to its persistence in poultry houses. There is only one serotype of CAV, but multiple genotypes have been identified based on nucleotide sequence analysis of the VP1 gene, which encodes the major capsid protein. These genotypes show varying pathogenicity, with some strains being more virulent than others. The virus replicates in lymphoid precursor cells, particularly in the thymus and bone marrow, leading to depletion of T-lymphocytes and erythroid and myeloid progenitor cells. CAV also replicates in the bursa of Fabricius, causing atrophy of the bursal follicles. The virus is transmitted both vertically (transovarially) and horizontally (fecal-oral and respiratory routes). Vertical transmission is particularly important in breeder flocks, as infected hens can shed the virus in eggs for several weeks after infection. Horizontal transmission occurs through contaminated feces, feed, water, and fomites, and the virus can also be spread by contaminated vaccines and equipment.

Chicken infectious anemia is endemic in most poultry-producing countries, with serological surveys indicating that the majority of commercial chicken flocks are exposed to CAV. The disease is most commonly seen in broiler chicks between 2 and 4 weeks of age, when maternal antibody levels decline. Chicks from unvaccinated or poorly vaccinated breeder flocks are at highest risk. In commercial layers and broiler breeders, clinical disease is less common due to age-related resistance, but subclinical infections can occur and lead to immunosuppression and reduced performance. The virus is transmitted both vertically and horizontally. Vertical transmission occurs when hens become infected during the laying period, leading to the virus being present in the egg and infecting the embryo. Chicks hatched from such eggs may show clinical signs within 1-2 weeks of age. Horizontal transmission occurs through the fecal-oral route, as the virus is shed in feces and can contaminate feed, water, litter, and equipment. The virus can also be spread through contaminated vaccines, particularly live vaccines of chicken embryo origin. The incubation period is typically 7-14 days. Morbidity can be as high as 100% in susceptible flocks, while mortality typically ranges from 5% to 30%, but can be higher in the presence of secondary infections. The disease can cause significant economic losses due to increased mortality, reduced weight gain, poor feed conversion ratio (FCR), and increased condemnation at slaughter. In layer flocks, egg production may drop by 10-20% during the acute phase, with a slow recovery over several weeks. The virus is highly resistant in the environment, and contaminated poultry houses can remain a source of infection for months. Biosecurity measures, including all-in/all-out management, thorough cleaning and disinfection, and vaccination of breeders, are essential for control.

The pathogenesis of chicken infectious anemia begins with the oral or respiratory entry of the virus, followed by primary replication in the respiratory and intestinal epithelium. The virus then spreads via the bloodstream to target organs, particularly the thymus, bone marrow, and bursa of Fabricius. In the thymus, CAV infects and destroys cortical thymocytes, leading to severe thymic atrophy and depletion of T-lymphocytes. This results in profound immunosuppression, affecting both cell-mediated and humoral immune responses. In the bone marrow, the virus infects erythroid and myeloid progenitor cells, causing aplastic anemia characterized by a marked decrease in circulating erythrocytes, leukocytes, and thrombocytes. The anemia is typically severe, with packed cell volumes (PCV) dropping below 20% (normal is 30-35%). The destruction of thrombocytes leads to hemorrhagic diathesis, with petechial and ecchymotic hemorrhages on the skin, muscles, and internal organs. In the bursa of Fabricius, CAV causes atrophy of the bursal follicles, leading to depletion of B-lymphocytes and reduced antibody production. The combined effects of T-cell and B-cell depletion result in severe immunosuppression, making the bird highly susceptible to secondary infections, including colibacillosis, gangrenous dermatitis, and respiratory diseases. The virus also causes a transient viremia, which can be detected by PCR or virus isolation. The severity of the disease is influenced by the age of the bird, the virulence of the viral strain, and the presence of maternal antibodies. Chicks with maternal antibodies are protected during the first few weeks of life, but as antibody levels wane, they become susceptible. The virus can also cause persistent infection in some birds, leading to chronic immunosuppression and poor performance.

Several intrinsic and extrinsic factors predispose chickens to clinical chicken infectious anemia. Intrinsic factors include age, as chicks are most susceptible between 2 and 4 weeks of age, when maternal antibody levels are declining. Genetic susceptibility may also play a role, with some commercial broiler lines being more susceptible than others. Immune status is critical; birds that are immunosuppressed due to other infections, such as infectious bursal disease (IBD) or Marek's disease (MD), are more likely to develop severe CIA. Stress factors, such as high stocking density, poor ventilation, and nutritional deficiencies, can also increase susceptibility. Extrinsic factors include poor biosecurity, which allows the introduction and spread of the virus. The virus is highly resistant in the environment, and contaminated poultry houses, equipment, and vehicles can serve as sources of infection. Vertical transmission from infected breeders is a major risk factor, as chicks can be infected in ovo. Vaccination failures, particularly with live vaccines that are contaminated with CAV, can also lead to outbreaks. Poor hygiene and sanitation practices, such as inadequate cleaning and disinfection between flocks, can perpetuate the virus in the environment. Additionally, the presence of other pathogens, such as E. coli, can exacerbate the clinical signs and increase mortality.

The clinical signs of chicken infectious anemia vary depending on the age of the bird and the presence of secondary infections. In young chicks (2-4 weeks of age), the disease is characterized by sudden onset of depression, anorexia, and reluctance to move. Affected chicks often huddle together for warmth and show pale combs and wattles due to anemia. The skin may appear pale or yellowish, and there may be petechial or ecchymotic hemorrhages on the skin, particularly on the wings and abdomen. In some cases, gangrenous dermatitis may develop, characterized by dark, necrotic lesions on the skin, especially on the wings, thighs, and abdomen. Respiratory signs, such as coughing and sneezing, may be present if secondary respiratory infections occur. The chicks may also show diarrhea, which can be watery or bloody. Growth is severely retarded, and feed conversion is poor. Mortality typically peaks within 1-2 weeks after the onset of clinical signs and can range from 5% to 30%. In older birds (layers and breeders), clinical disease is less common, but subclinical infections can cause a drop in egg production, reduced egg quality, and increased susceptibility to other diseases. In broiler flocks, the disease may be detected at processing due to increased condemnation rates for anemia, emaciation, and skin lesions. Neurological signs, such as ataxia and paralysis, are rare but can occur if the virus affects the central nervous system. The severity of clinical signs is influenced by the presence of secondary infections, which can complicate the clinical picture and increase mortality.

The differential diagnoses for chicken infectious anemia include other causes of anemia, immunosuppression, and hemorrhagic syndromes in young chickens. Key differentials include: 1) Infectious bursal disease (IBD): Both diseases cause immunosuppression and bursal atrophy, but IBD typically causes severe bursal inflammation and swelling in the acute phase, followed by atrophy. CIA causes thymic atrophy and bone marrow aplasia, which are not typical of IBD. PCR and virus isolation can differentiate the two. 2) Marek's disease (MD): MD can cause immunosuppression and visceral tumors, but it typically affects older birds (6-20 weeks) and causes neurological signs and lymphoid tumors. CIA does not cause tumors. 3) Hemorrhagic syndrome due to toxic agents, such as sulfonamide toxicity or mycotoxins (e.g., aflatoxin): These can cause anemia and hemorrhage, but they are not associated with thymic atrophy. Feed analysis and histopathology can help differentiate. 4) Avian leukosis virus (ALV) infection: ALV can cause immunosuppression and tumors, but it is less common in commercial flocks and typically causes lymphoid leukosis in older birds. 5) Reticuloendotheliosis virus (REV) infection: REV can cause immunosuppression and runting, but it is rare and can be differentiated by PCR. 6) Bacterial septicemias, such as colibacillosis or salmonellosis, can cause anemia and hemorrhage, but they are usually associated with specific lesions, such as fibrinous pericarditis or hepatitis. 7) Nutritional deficiencies, such as vitamin K deficiency, can cause hemorrhage, but they are not associated with thymic atrophy. 8) Other viral infections, such as avian influenza or Newcastle disease, can cause systemic signs, but they are typically more severe and have respiratory or neurological signs. Definitive diagnosis of CIA requires laboratory testing, including PCR, virus isolation, or serology.

The diagnostic algorithm for chicken infectious anemia begins with a thorough flock history, including age, vaccination status, maternal antibody status, and clinical signs. A complete necropsy examination should be performed on affected birds, with particular attention to the thymus, bone marrow, and bursa of Fabricius. Gross lesions include thymic atrophy, pale bone marrow, and bursal atrophy. Blood samples should be collected for hematology, including packed cell volume (PCV) and complete blood count (CBC), which typically show severe anemia (PCV < 20%) and leukopenia. Serological testing, such as ELISA, can detect antibodies to CAV, but it is more useful for monitoring flock exposure than for diagnosing acute infection. Molecular diagnostics, such as PCR or real-time PCR, can detect viral DNA in tissues, blood, or feces and are the preferred method for confirming the diagnosis. Virus isolation can be performed in MDCC-MSB1 cells, but it is time-consuming and requires specialized facilities. Histopathology of the thymus, bone marrow, and bursa can reveal characteristic lesions, including lymphoid depletion and aplasia. Differential diagnoses should be ruled out based on clinical signs, lesions, and laboratory findings. A definitive diagnosis is based on the combination of clinical signs, gross lesions, histopathology, and positive PCR or virus isolation. It is important to consider the possibility of secondary infections, which may complicate the diagnosis and require additional testing.

Laboratory findings in chicken infectious anemia include hematological, serological, and molecular abnormalities. Hematology typically reveals severe anemia, with packed cell volume (PCV) dropping below 20% (normal is 30-35%). Complete blood count shows a marked decrease in erythrocytes, leukocytes, and thrombocytes. Serum biochemistry may show elevated liver enzymes (AST, ALT) and bilirubin due to hepatic damage. Serological testing using ELISA can detect antibodies to CAV, but antibody levels may be low in acutely infected birds. The presence of maternal antibodies can complicate interpretation. Molecular diagnostics, such as PCR or real-time PCR, can detect viral DNA in tissues (thymus, bone marrow, liver), blood, or feces. PCR is highly sensitive and specific and is the preferred method for confirming the diagnosis. Virus isolation can be performed in MDCC-MSB1 cells, but it is time-consuming and requires specialized facilities. Histopathology of the thymus shows severe lymphoid depletion, with loss of cortical thymocytes. The bone marrow shows aplasia, with depletion of erythroid and myeloid precursors. The bursa of Fabricius shows atrophy of the follicles, with depletion of B-lymphocytes. Immunohistochemistry can be used to detect viral antigens in tissues. In addition, testing for secondary infections, such as bacterial culture or PCR for other viruses, may be warranted. Feed analysis for mycotoxins may be indicated if toxic causes are suspected.

Imaging modalities are not commonly used in the diagnosis of chicken infectious anemia, but they can be helpful in certain situations. Radiography may be used to assess the skeletal system, particularly in cases of secondary bacterial infections that cause osteomyelitis or femoral head necrosis. However, these findings are nonspecific. Ultrasonography is not typically used in poultry, but it may be used to evaluate the liver or spleen in cases of suspected secondary infections. Gross necropsy photography is an important tool for documenting lesions, such as thymic atrophy, pale bone marrow, and bursal atrophy. These images can be used for diagnostic reference and for educational purposes. In research settings, advanced imaging techniques, such as computed tomography (CT) or magnetic resonance imaging (MRI), may be used to evaluate the effects of the virus on internal organs, but these are not practical for routine diagnosis. Overall, imaging plays a limited role in the diagnosis of CIA, and the primary diagnostic methods are clinical signs, necropsy, and laboratory testing.

Gross necropsy lesions in chicken infectious anemia include severe thymic atrophy, which may be so severe that the thymus is difficult to identify. The bone marrow is pale or white due to aplasia. The bursa of Fabricius is atrophied and may be smaller than normal. Petechial and ecchymotic hemorrhages may be present on the skin, muscles, and internal organs. The liver may be swollen and pale. In cases of secondary infections, additional lesions may be present, such as fibrinous pericarditis, airsacculitis, or gangrenous dermatitis. Histopathology reveals severe lymphoid depletion in the thymus, with loss of cortical thymocytes and a reduction in the overall size of the thymic lobules. The bone marrow shows aplasia, with a marked decrease in hematopoietic cells and an increase in adipose tissue. The bursa of Fabricius shows atrophy of the follicles, with depletion of B-lymphocytes and a reduction in the number of follicles. The spleen may also show lymphoid depletion. In the liver, there may be hepatocellular degeneration and necrosis. Intranuclear inclusion bodies are not typically seen in CIA, but viral antigens can be detected by immunohistochemistry. The presence of secondary bacterial infections can be confirmed by histopathology, with evidence of inflammation and bacterial colonies. Cytological examination of bone marrow aspirates may show a decrease in erythroid and myeloid precursors. Overall, the histopathological lesions are characteristic and can support a diagnosis of CIA when combined with clinical signs and laboratory findings.

There is no specific antiviral treatment for chicken infectious anemia. Treatment is primarily supportive and aimed at reducing the impact of secondary infections and improving the bird's immune status. Supportive care includes providing a clean, warm, and stress-free environment. Affected chicks should be given easy access to feed and water. Vitamin and electrolyte supplements may be added to the drinking water to support the birds during recovery. Vitamin K supplementation may be beneficial to help control hemorrhage. Antibiotics may be administered to control secondary bacterial infections, such as colibacillosis or gangrenous dermatitis. Common antibiotics used in poultry include amoxicillin (10-20 mg/kg body weight orally, or 250-500 mg/L drinking water for 3-5 days), oxytetracycline (10-20 mg/kg body weight, or 200-400 mg/L drinking water for 3-5 days), and tylosin (20-50 mg/kg body weight, or 500 mg/L drinking water for 3-5 days). The choice of antibiotic should be based on culture and sensitivity testing. Anticoccidial drugs may be indicated if coccidiosis is present. In severe outbreaks, depopulation may be considered to prevent the spread of the virus and to reduce economic losses. Vaccination of breeder flocks is the most effective control measure, as it provides maternal immunity to chicks. Live vaccines are available and are typically administered to breeders during the rearing period, before the onset of egg production. Inactivated vaccines are also available for use in breeders. Biosecurity measures, including all-in/all-out management, thorough cleaning and disinfection, and control of fomites, are essential to prevent the introduction and spread of the virus.

The prognosis for chicken infectious anemia depends on the age of the birds, the presence of secondary infections, and the management practices. In young chicks (2-4 weeks of age), the disease can cause significant mortality, typically ranging from 5% to 30%. With supportive care and control of secondary infections, the mortality rate can be reduced. Birds that survive the acute phase may recover within 2-3 weeks, but they may have permanent immunosuppression and poor growth performance. The feed conversion ratio (FCR) may be permanently affected, leading to reduced profitability. In layer flocks, egg production may drop by 10-20% during the acute phase, with a slow recovery over several weeks. Egg quality may also be affected, with an increase in shell defects. In broiler flocks, the disease may lead to increased condemnation rates at processing due to anemia, emaciation, and skin lesions. The long-term prognosis for the flock is generally good if the disease is managed properly, but the economic impact can be significant. In severe outbreaks, depopulation may be necessary to prevent the spread of the virus and to reduce losses. The prognosis is worse in flocks with concurrent infections, such as IBD or MD, which can exacerbate the immunosuppression and increase mortality.

Following an outbreak of chicken infectious anemia, it is important to implement a structured flock monitoring program to assess recovery and prevent recurrence. Serial serological monitoring using ELISA can be used to track antibody levels in the flock. In breeders, it is important to ensure that all birds are vaccinated and have adequate antibody levels to provide maternal immunity to progeny. Post-outbreak cleaning and disinfection of the poultry house is critical to eliminate the virus from the environment. The virus is highly resistant, so thorough cleaning with detergent and water, followed by disinfection with an effective disinfectant, such as a phenolic or aldehyde-based product, is necessary. Litter should be removed and disposed of properly. The house should be left empty for a period of time (at least 2 weeks) to allow any remaining virus to die. All equipment and vehicles should be cleaned and disinfected. Biosecurity measures should be reviewed and strengthened to prevent the introduction of the virus from outside sources. In pullet rearing, it is important to monitor for signs of immunosuppression and to ensure that vaccination programs are effective. Regular necropsy examinations of birds that die should be performed to monitor for secondary infections. The flock should be monitored for growth performance, feed conversion, and egg production to assess the long-term impact of the disease. A review of the vaccination program for breeders is essential to ensure that maternal immunity is adequate.

Clinical pearls: 1) In young chicks with severe anemia and thymic atrophy, chicken infectious anemia should be high on the differential list. 2) The presence of gangrenous dermatitis in young broilers is often associated with CIA-induced immunosuppression. 3) Maternal immunity is critical for protection; therefore, vaccination of breeders is the most effective control measure. 4) The virus is highly resistant in the environment, so thorough cleaning and disinfection are essential. 5) Subclinical infections can exacerbate other diseases, so consider CIA in flocks with poor performance or increased susceptibility to secondary infections. Pitfalls: 1) Do not confuse CIA with infectious bursal disease (IBD) based solely on bursal atrophy; thymic atrophy and bone marrow aplasia are more specific for CIA. 2) Serology is not useful for diagnosing acute infection, as antibodies may not be present until later. 3) PCR is the preferred diagnostic method, but it is important to collect appropriate samples (thymus, bone marrow, liver) for testing. 4) Do not overlook the possibility of secondary infections, which can complicate the clinical picture and require additional treatment. 5) Avoid using live vaccines that may be contaminated with CAV; ensure that vaccines are from reputable sources. 6) Do not rely solely on antibiotics to treat the disease; supportive care and biosecurity are equally important.

There is no specific antiviral treatment for chicken infectious anemia. Supportive care and control of secondary infections are the mainstays of therapy. Antibiotics may be administered in the drinking water or feed to control bacterial infections. Common protocols include: Amoxicillin: 10-20 mg/kg body weight orally, or 250-500 mg/L drinking water for 3-5 days. Oxytetracycline: 10-20 mg/kg body weight, or 200-400 mg/L drinking water for 3-5 days. Tylosin: 20-50 mg/kg body weight, or 500 mg/L drinking water for 3-5 days. Enrofloxacin (where legal): 10 mg/kg body weight, or 50-100 mg/L drinking water for 3-5 days. Florfenicol: 20-30 mg/kg body weight, or 400 mg/L drinking water for 3-5 days. Anticoccidials may be indicated if coccidiosis is present. Amprolium: 125-250 mg/L drinking water for 3-5 days, or 125 g/ton feed. Toltrazuril: 25 mg/L drinking water for 2 days. Ionophores, such as monensin (100-120 g/ton feed) or salinomycin (60-70 g/ton feed), can be used for prevention. Vitamin supplementation is important for recovery. Vitamin K: 1-2 mg/kg feed or 0.5-1 mg/L drinking water. Vitamin C: 100-200 mg/L drinking water. Vitamin E: 100-200 IU/kg feed. Electrolytes and glucose can be added to drinking water to support hydration and energy. Vaccination of breeders is the most effective control measure. Live vaccines are available and are typically administered to breeders between 8 and 16 weeks of age, but before the onset of egg production. Inactivated vaccines are also available for use in breeders. The withdrawal times for antibiotics must be observed according to local regulations.

Chicken infectious anemia has been extensively studied since its first description in 1979 by Yuasa et al. in Japan. The virus was initially isolated from contaminated Marek's disease vaccines, highlighting the importance of vaccine purity. Subsequent research has characterized the virus's genome, pathogenesis, and epidemiology. Key studies have demonstrated the immunosuppressive effects of CAV, including the depletion of T-lymphocytes and the increased susceptibility to secondary infections. A landmark study by McNulty et al. (1990) established the role of maternal antibodies in protecting chicks from clinical disease. Vaccination of breeders has been shown to be highly effective in preventing vertical transmission and providing passive immunity to progeny. Studies have also evaluated the economic impact of CIA, with estimates of losses due to mortality, reduced growth, and increased condemnation. The development of PCR-based diagnostics has greatly improved the ability to detect the virus in clinical samples. Recent research has focused on the molecular epidemiology of CAV, with the identification of multiple genotypes and their varying pathogenicity. Consensus guidelines from the World Organisation for Animal Health (WOAH) and the American Association of Avian Pathologists (AAAP) recommend vaccination of breeders and strict biosecurity measures to control the disease. Overall, the literature supports the importance of CIA as a significant pathogen in poultry, and the need for continued surveillance and research to improve control strategies.